Study guide
1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models
Key Takeaways Explain This Topic AI
The secondary prevention continuum progresses through 4 distinct phases: Phase I (inpatient, 1.5–3.0 METs), Phase II (early outpatient medically supervised, 36 covered sessions), Phase III (maintenance/continuation), and Phase IV (independent community wellness).
Medicare covers Phase II cardiac rehabilitation for up to 36 1-hour sessions (maximum 2 sessions per day) under NCD 20.10 for 7 qualifying cardiovascular indications.
Heart failure patients qualify under CMS guidelines if they demonstrate stable chronic HFrEF with LVEF <=35%, NYHA Class II–IV symptoms, and >=6 weeks of optimal guideline-directed medical therapy.
Sternal precautions following median sternotomy require avoiding bilateral pushing/pulling >5–10 pounds, minimizing unilateral shoulder extension behind the back, and splinting coughs for 6–8 weeks.
Joint AACVPR/AHA/ACC scientific statements confirm that structured Home-Based Cardiac Rehabilitation (HBCR) provides equivalent improvements in peak METs, blood pressure, and lipids compared to center-based CR for low-to-moderate risk patients.
Last updated: September 2026
1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models
Note
The Secondary Prevention Continuum : Modern cardiac rehabilitation is organized as a four-phase continuum of care extending from acute inpatient bedside mobilization through lifelong independent community-based maintenance. Each phase addresses unique physiological, safety, and behavioral priorities designed to arrest atherosclerosis progression and restore functional independence.
Cardiac rehabilitation is a medically supervised, multidisciplinary intervention designed to optimize cardiovascular health, minimize disability, and attenuate coronary artery disease progression. The clinical delivery model spans four sequential phases. While inpatient Phase I and outpatient Phase II represent the formal medicalized components governed by acute hospital guidelines and Centers for Medicare & Medicaid Services (CMS) coverage mandates, Phases III and IV sustain long-term physical activity, risk reduction, and independent self-management across a patient's lifespan.
The Four-Phase Continuum of Cardiac Rehabilitation
Understanding the physiological objectives, monitoring protocols, and safety precautions of each phase is essential for secondary prevention practice:
Phase Setting & Supervision Level Primary Clinical Objectives Telemetry & Monitoring Protocols
Phase I Inpatient hospital unit; direct bedside clinical supervision Early progressive mobilization; prevent deconditioning; patient and caregiver education Continuous telemetry; orthostatic vitals; RPE monitoring (Borg <= 13)
Phase II Early outpatient center; direct practitioner supervision (physician or PA/NP/CNS since 2024) Aerobic and resistance reconditioning; comprehensive risk factor modification; ITP formulation Continuous ECG telemetry; pre-, during, and post-exercise blood pressure
Phase III Outpatient clinic or clinical wellness center; intermediate supervision Sustained exercise adherence; independent risk factor tracking; peer support Intermittent ECG or spot rhythm checks; self-monitored heart rate and RPE
Phase IV Community fitness centers, YMCA, or home; independent self-care Lifelong maintenance of physical fitness; ongoing secondary prevention self-management Independent self-monitoring (pulse, fitness trackers, RPE)
Phase I: Inpatient / Acute Phase
Initiated within 24 to 48 hours of an acute cardiac event or surgical procedure once the patient is hemodynamically stable. Clinical priorities include:
Early Mobilization : Progression from passive range of motion (ROM) to active bedside sitting, standing, and progressive hallway ambulation targeting 1.5 to 3.0 Metabolic Equivalents (METs) .
Hemodynamic Limits : Activity is terminated if resting heart rate increases by >20–30 beats/minute above baseline (or exceeds 120 bpm), systolic blood pressure drops by >10 mmHg, or systolic blood pressure exceeds 200 mmHg.
Sternal Precautions : Following median sternotomy for coronary artery bypass graft (CABG) or valve surgery, patients must adhere to strict sternal precautions for 6 to 8 weeks to ensure bone healing and avoid nonunion. Precautions include avoiding unilateral pulling/pushing, restricting lifting to <5 to 10 pounds , avoiding reaching behind the back with both arms, and splinting the sternum with a pillow during coughing or deep breathing.
Discharge Preparation : Education on warning signs of recurrent ischemia, medication reconciliation, and coordinating a warm handoff referral to outpatient Phase II.
Phase II: Early Outpatient Medically Supervised Phase
Phase II begins 1 to 3 weeks following percutaneous intervention or acute myocardial infarction, and 4 to 6 weeks following median sternotomy.
Session Allowance : CMS reimburses up to 36 one-hour sessions , typically delivered 3 times per week over 12 weeks. CMS permits a maximum of 2 one-hour sessions per calendar day .
Monitoring & Safety : Continuous ECG telemetry monitoring is standard during Phase II exercise sessions to detect exertional arrhythmias, ST-segment changes, or conduction abnormalities.
Core Components : Baseline clinical assessment, individualized exercise prescription (FITT-VP), nutritional counseling, psychosocial screening, lipid and glycemic optimization, and formulation of an Individualized Treatment Plan (ITP) reviewed by a physician every 30 days.
Phase III: Maintenance / Intermediate Phase
Phase III is an outpatient continuation program (often self-pay or non-covered) bridging Phase II and community fitness:
Transition to Independence : Patients who have completed Phase II but desire continued clinical structure exercise with minimal telemetry or intermittent spot-monitoring.
Focus : Reinforcing independent exercise adherence, tracking blood pressure and lipid trends, and fostering long-term behavioral changes within a supportive clinical environment.
Phase IV: Long-Term Community & Independent Maintenance
Phase IV represents permanent, lifelong independent maintenance:
Environment : Community fitness centers, corporate wellness programs, senior community centers, or home-based exercise routines.
Clinical Role : Patients self-manage cardiovascular risk factors, maintain at least 150 minutes of moderate-intensity aerobic exercise weekly, and undergo periodic primary care or cardiology follow-up.
Alternative, Virtual, and Hybrid Delivery Models
Despite proven mortality benefits, traditional center-based Phase II cardiac rehabilitation experiences significant underutilization, with only 20% to 30% of eligible patients enrolling nationally. Common barriers include geographic distance, transportation limitations, scheduling conflicts with employment, and family caregiving obligations.
Home-Based Cardiac Rehabilitation (HBCR) and Hybrid CR
To address these barriers, the AACVPR, American Heart Association (AHA), and American College of Cardiology (ACC) issued joint scientific statements endorsing Home-Based Cardiac Rehabilitation (HBCR) and hybrid delivery models :
Technological Architecture : Utilizes remote physiological monitoring, cellular-connected blood pressure cuffs, wearable digital biosensors (continuous single-lead ECG or heart rate monitors), secure video visits, and validated smartphone applications.
Clinical Efficacy : Extensive clinical trials demonstrate that structured HBCR achieves equivalent improvements in peak functional capacity (METs), blood pressure reduction, lipid control, and smoking cessation rates compared to center-based Phase II CR.
Safety Profile : HBCR demonstrates an exceptionally low major adverse cardiovascular event (MACE) rate when restricted to low-to-moderate risk patients . Low-risk criteria include preserved left ventricular ejection fraction (LVEF >40%), absence of complex ventricular arrhythmias, functional capacity >7 METs on stress testing, and absence of exertional ischemia.
High-Risk Exclusions : Patients with high-risk features—such as severe left ventricular dysfunction (LVEF <30%), unstable angina, exercise-induced ventricular tachycardia, or severe uncorrected valvular stenosis—are not candidates for unmonitored home-based models and mandate center-based telemetry supervision.
CMS Qualifying Indications and Coverage Mandates
Under Medicare National Coverage Determination (NCD 20.10), Phase II outpatient cardiac rehabilitation is reimbursed for 7 specific qualifying cardiovascular indications:
- CMS Qualifying Indication Clinical Coverage Criteria & Documentation Mandates
- Acute Myocardial Infarction (AMI) Documented within the preceding 12 months of Phase II enrollment
- Coronary Artery Bypass Graft (CABG) Median sternotomy surgical revascularization; sternal stability verified
- Stable Angina Pectoris Documented chronic stable angina refractory to medical therapy or angiographic CAD
- Heart Valve Repair or Replacement Surgical or transcatheter (e.g., TAVR) valve repair or replacement
- Percutaneous Coronary Intervention (PCI) Balloon angioplasty or coronary artery stent placement
- Heart or Heart-Lung Transplantation Post-transplant recipient; ongoing immunosuppression monitoring
Stable Chronic Heart Failure (HFrEF) LVEF <= 35% , NYHA Class II to IV , on optimal medical therapy for >= 6 weeks
Specific CMS Coverage Mandates for Chronic Heart Failure (HFrEF)
Medicare coverage for heart failure patients requires strict compliance with three clinical criteria:
Severely Reduced Ejection Fraction : Documented left ventricular ejection fraction of 35% or less on echocardiography, ventriculography, or radionuclide imaging.
Functional Symptom Severity : New York Heart Association (NYHA) functional Class II, III, or IV symptoms despite optimal medical therapy.
Clinical Regimen Stability : Maintained on stable guideline-directed medical therapy (GDMT—including beta-blockers, ACEi/ARB/ARNI, aldosterone antagonists, and SGLT2 inhibitors) for a minimum of 6 consecutive weeks , with no cardiovascular hospitalizations or planned invasive cardiac procedures during the preceding 6 weeks.
Realistic Clinical Scenario: Complex Phase Transition and Eligibility Audit
Clinical Scenario : A 67-year-old male is evaluated 3 weeks following a 3-vessel CABG. His postoperative recovery was complicated by new-onset atrial fibrillation, which is now rate-controlled on metoprolol succinate and apixaban. His predischarge echocardiogram revealed an LVEF of 45%. He is referred to Phase II outpatient cardiac rehabilitation.
Clinical Management & Phase Rules :
CMS Indication : CABG surgery is a primary qualifying indication under CMS NCD 20.10. The patient is eligible for up to 36 sessions.
Sternal Healing Precautions : At 3 weeks post-surgery, sternal bone union is incomplete. The CR team enforces sternal precautions (no lifting >5–10 lbs, no unilateral push/pull on upper body ergometers, splinting with cough) through post-op week 8. Upper body resistance training is deferred until sternal stability is confirmed.
Telemetry Monitoring : Given new-onset atrial fibrillation and recent surgical revascularization, the patient is assigned continuous ECG telemetry monitoring during Phase II exercise sessions to monitor ventricular response rate and screen for transient ischemia.